| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 4 | |
| #2 | Canada | 3 | |
| #3 | EPO (European Patent Office) | 3 | |
| #4 | Norway | 3 | |
| #5 | Israel | 2 | |
| #6 | Iceland | 2 | |
| #7 | WIPO (World Intellectual Property Organization) | 2 | |
| #8 | Germany | 1 | |
| #9 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology | |
| #4 | Agriculture |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Microorganisms | |
| #5 | Climate change adaptation technologies | |
| #6 | Animal care |
| # | Name | Total Patents |
|---|---|---|
| #1 | Tschopp Jurg | 11 |
| #2 | Hahne Michael | 9 |
| #3 | Tschopp Juerg | 7 |
| #4 | Schroeter Michael | 7 |
| #5 | Schneider Pascal | 6 |
| #6 | Irmler Martin | 4 |
| #7 | Thome Margot | 4 |
| #8 | Rimoldi Donata | 4 |
| #9 | Bodmer Jean-Luc | 4 |
| #10 | Burns Kimberly | 4 |
| Publication | Filing date | Title |
|---|---|---|
| AU2003213481A1 | APRIL - A Novel Protein With Growth Effects | |
| ZA9810745B | Novel receptor-OPG2 | |
| AU8799698A | Anti-flip protein antibodies | |
| DE19643093A1 | Use of FasL or CD4 · + · / FasL · - · / TH1 cell lines transfected with FasL or of FasL in combination with one or more cytokines for combating TH1 / TH2 diseases |